Does teriparatide injection affect blood pressure?

There is no clear evidence that Teriparatide injection directly affects blood pressure in clinical use. However, some patients may experience minor blood pressure-related changes while taking teriparatide, especially if they are affected by other side effects caused by the drug (such as hypercalcemia). For example, elevated blood calcium levels may cause reactions in the cardiovascular system that indirectly affect blood pressure. These changes in blood pressure are usually mild, but still cause for concern.

There is a correlation between hypercalcemia and increased blood pressure. Teriparatide may cause an increase in blood calcium concentrations by promoting bone formation and calcium release. Hypercalcemia may cause vasoconstriction, leading to an increase in blood pressure. In addition, hypercalcemia may cause symptoms such as nausea, vomiting, and fatigue, which may indirectly affect posture or mood, thereby causing temporary blood pressure fluctuations. Therefore, regular monitoring of blood calcium levels and blood pressure is necessary during teriparatide treatment to ensure safe use of the drug.

In some clinical reports, individual patients have experienced hypotension while taking teriparatide. This is often associated with fluid loss (such as dehydration due to hypercalcemia or other side effects). The side effects of teriparatide may affect the patient's drinking water and urinary excretion, resulting in changes in water and electrolyte balance, which may also affect blood pressure to a certain extent. In this regard, patients should maintain adequate fluid intake during treatment to avoid dehydration.

In general, teriparatide injection itself does not significantly affect blood pressure, but its potential adverse reactions (such as hypercalcemia) may indirectly cause blood pressure fluctuations. Therefore, patients should regularly check their blood pressure to ensure it is within the normal range while using this drug, especially during the initial treatment period and after drug dose adjustment. If there are any abnormal changes, promptly communicate with your doctor for adjustments.